CAFs have been shown to support tumor cells through exosomal transfer and the paracrine signaling mediated by NF-κB and cytokines such as IL-6, thereby activating the downstream JAK/STAT3, mechanistic target of rapamycin (mTOR), and SHH pathways[184,186]. Here, MTOR is linked to neoplasm.